Biggest changeAfter its deconsolidation, NuScale is included in equity method earnings on our statement of operations. 32 Table of Contents Results of Operations YEAR ENDED DECEMBER 31, (in millions) 2024 2023 2022 Revenue Urban Solutions $ 7,239 $ 5,262 $ 4,373 Energy Solutions 5,976 6,307 5,872 Mission Solutions 2,594 2,655 2,289 Other 506 1,250 1,210 Total revenue $ 16,315 $ 15,474 $ 13,744 Segment profit (loss) $ and margin % Urban Solutions $ 304 4.2 % $ 268 5.1 % $ 17 0.4 % Energy Solutions 256 4.3 % 381 6.0 % 301 5.1 % Mission Solutions 153 5.9 % 116 4.4 % 136 5.9 % Other (78) NM (228) NM (27) NM Total segment profit $ and margin % (1) $ 635 3.9 % $ 537 3.5 % $ 427 3.1 % G&A (203) (232) (237) Impairment — — 24 Gain on pension settlement — — 42 Foreign currency gain (loss) 92 (98) 25 Interest income (expense), net 150 168 35 Earnings (loss) attributable to NCI (61) (60) (72) Earnings before taxes 613 315 244 Income tax expense (including $376 million attributable to equity method earnings in 2024) (634) (236) (171) Net earnings before equity method earnings (21) 79 73 Equity method earnings 2,105 — — Net earnings 2,084 79 73 Less: Net earnings (loss) attributable to NCI (61) (60) (72) Net earnings attributable to Fluor 2,145 139 145 Less: Dividends on CPS — 29 39 Less: Make-whole payment on conversion of CPS — 27 — Net earnings available to Fluor common stockholders $ 2,145 $ 83 $ 106 New awards Urban Solutions $ 9,493 $ 10,141 $ 6,900 Energy Solutions 3,246 6,871 6,512 Mission Solutions 1,910 1,055 5,347 Other 474 1,461 1,056 Total new awards $ 15,123 $ 19,528 $ 19,815 New awards related to projects located outside of the U.S. 38 % 76 % 46 % (in millions) December 31, 2024 December 31, 2023 Backlog (2)(3) Urban Solutions $ 17,749 $ 14,848 Energy Solutions 7,605 9,722 Mission Solutions 2,727 3,945 Other 403 926 Total backlog $ 28,484 $ 29,441 Backlog related to projects located outside of the U.S. 55 % 62 % Backlog related to reimbursable projects 79 % 76 % 33 Table of Contents (1) Total segment profit and margin are non-GAAP financial measures.
Biggest changeThe sale is expected to close in 2026, subject to the conditions in the agreement. 32 Table of Contents Results of Operations YEAR ENDED DECEMBER 31, (in millions) 2025 2024 2023 Revenue (1) Urban Solutions $ 9,200 $ 7,239 $ 5,262 Energy Solutions 3,554 5,976 6,307 Mission Solutions 2,720 2,594 2,655 Other 29 506 1,250 Total revenue $ 15,503 $ 16,315 $ 15,474 Segment profit (loss) $ and margin % Urban Solutions $ 205 2.2 % $ 304 4.2 % $ 268 5.1 % Energy Solutions (414) NM 256 4.3 % 381 6.0 % Mission Solutions 94 3.5 % 153 5.9 % 116 4.4 % Other 6 NM (78) NM (228) NM Total segment profit (loss) $ and margin % (2) $ (109) (0.7) % $ 635 3.9 % $ 537 3.5 % G&A (196) (203) (232) Foreign currency gain (loss) (62) 92 (98) Interest income (expense), net 67 150 168 Earnings (loss) attributable to NCI (11) (61) (60) Earnings (loss) before taxes (311) 613 315 Income tax benefit (expense) (including $92 million and $(376) million attributable to equity method earnings in 2025 and 2024, respectively) 39 (634) (236) Net earnings (loss) before equity method earnings (272) (21) 79 Equity method earnings 210 2,105 — Net earnings (loss) (62) 2,084 79 Less: Net earnings (loss) attributable to NCI (11) (61) (60) Net earnings (loss) attributable to Fluor (51) 2,145 139 Less: Dividends on CPS — — 29 Less: Make-whole payment on conversion of CPS — — 27 Net earnings (loss) available to Fluor common stockholders $ (51) $ 2,145 $ 83 New awards Urban Solutions $ 8,688 $ 9,493 $ 10,141 Energy Solutions 1,421 3,246 6,871 Mission Solutions 1,847 1,910 1,055 Other — 474 1,461 Total new awards $ 11,956 $ 15,123 $ 19,528 New awards related to projects located outside of the U.S. 26 % 38 % 76 % (in millions) December 31, 2025 December 31, 2024 Backlog (3)(4) Urban Solutions $ 18,746 $ 17,749 Energy Solutions 4,601 7,605 Mission Solutions 2,189 2,727 Other — 403 Total backlog $ 25,536 $ 28,484 Backlog related to projects located outside of the U.S. 40 % 55 % Backlog related to reimbursable projects 81 % 79 % 33 Table of Contents (1) In addition to the measurements under GAAP, we measure our performance by analyzing trends in adjusted net revenue (and related margin), which we determine by reducing GAAP revenue to exclude at-cost revenue associated with reimbursable contracts for the following elements, where applicable: • amounts associated with unaffiliated subcontractor project costs that are billed to clients without meaningful markup; • amounts associated with costs of material that are billed to clients without meaningful markup; and • costs of CFM that are procured by our clients and which do not give rise to meaningful markup to our billings to clients.
If we lose visibility mid-project, we cease recognizing future CFM but do not de-recognize previous amounts of CFM. 37 Table of Contents Due to the nature of our industry, there is significant complexity in our estimation of total expected revenue and cost, for which we must make significant judgments.
If we lose visibility mid-project, we cease recognizing 37 Table of Contents future CFM but do not de-recognize previous amounts of CFM. Due to the nature of our industry, there is significant complexity in our estimation of total expected revenue and cost, for which we must make significant judgments.
Borrowings under the facility, which may be denominated in USD, EUR or GBP, bear interest at a base rate, plus an applicable borrowing margin. As of December 31, 2024 and through the issuance of this 10-K, we had not made any borrowings under our credit line.
Borrowings under the facility, which may be denominated in USD, EUR or GBP, bear interest at a base rate, plus an applicable borrowing margin. As of December 31, 2025 and through the issuance of this 10-K, we had not made any borrowings under our credit line.
Litigation and Matters in Dispute Resolution Item is described more fully in the Notes to Financial Statements. 38 Table of Contents LIQUIDITY AND CAPITAL RESOURCES Our liquidity arises from available cash and cash equivalents and marketable securities, cash generated from operations, capacity under our credit facility and, when necessary, access to capital markets.
Litigation and Matters in Dispute Resolution Item is described in the Notes to Financial Statements. 38 Table of Contents LIQUIDITY AND CAPITAL RESOURCES Our liquidity arises from available cash and cash equivalents and marketable securities, cash generated from operations, capacity under our credit facility and, when necessary, access to capital markets.
The prior and amended credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00, based upon total shareholders' equity excluding AOCI, a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.2 billion, all as defined in the amended credit facility, which may be reduced to $1.0 billion upon the repayment of debt.
This credit facility contains customary financial covenants, including a debt-to-capitalization ratio that cannot exceed 0.60 to 1.00, based upon total shareholders' equity excluding AOCI, a limitation on the aggregate amount of debt of the greater of $750 million or €750 million for our subsidiaries, and a minimum liquidity threshold of $1.1 billion, all as defined in the amended credit facility, which may be reduced to $1.0 billion upon the repayment of debt.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis should be read in conjunction with our financial statements. A discussion and analysis of the operating results of 2023 compared to 2022 are included in our 2023 10-K and have not been repeated in this 10-K.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis should be read in conjunction with our financial statements. A discussion and analysis of the operating results of 2024 compared to 2023 are included in our 2024 10-K and have not been repeated in this 10-K.
We also consider the extent to which client advances (which totaled $79 million and $80 million as of December 31, 2024 and 2023, respectively) are likely to be sustained or consumed over the near term for project execution activities and the cash flow requirements of our various foreign operations.
We also consider the extent to which client advances (which totaled $14 million and $79 million as of December 31, 2025 and 2024, respectively) are likely to be sustained or consumed over the near term for project execution activities and the cash flow requirements of our various foreign operations.
Guarantees The maximum potential amount of future payments that we could be required to make under outstanding performance guarantees, which represents the remaining cost of work to be performed, was estimated to be $16 billion as of December 31, 2024.
Guarantees The maximum potential amount of future payments that we could be required to make under outstanding performance guarantees, which represents the remaining cost of work to be performed, was estimated to be $14 billion as of December 31, 2025.
As of December 31, 2024, letters of credit totaling $944 million were outstanding under uncommitted lines of credit including letters of credit totaling $344 million for two lump-sum projects in Kuwait that are substantially complete except for the resolution of unapproved change orders and extension of time claims.
As of December 31, 2025, letters of credit totaling $918 million were outstanding under uncommitted lines of credit including letters of credit totaling $347 million for two lump-sum projects in Kuwait that are substantially complete except for the resolution of unapproved change orders and extension of time claims.
Investments in unconsolidated partnerships and joint ventures in 2024 included capital contributions to 3 infrastructure joint ventures and an Energy Solutions joint venture compared to capital contributions to 3 infrastructure joint ventures and a Mission Solutions joint venture in 2023. Return of capital from partnerships and joint ventures in 2024 included capital distribution from an infrastructure joint venture.
Investments in partnerships and joint ventures in 2024 included capital contributions to an infrastructure joint venture, an Energy Solutions joint venture and a Mission Solutions joint venture. Return of capital from partnerships and joint ventures in 2024 included capital distribution from an infrastructure joint venture.
We have a sublimit of up to $1.0 billion in aggregate cash advances and financial letters of credit available to us under our credit facility with a current borrowing capacity of $834 million. Cash and cash equivalents combined with marketable securities were $3.0 billion and $2.6 billion as of December 31, 2024 and 2023, respectively.
We have a sub-limit of up to $1.0 billion in aggregate cash advances and financial letters of credit available to us under our credit facility with a current borrowing capacity of $901 million. Cash and cash equivalents combined with marketable securities were $2.2 billion and $3.0 billion as of December 31, 2025 and 2024, respectively.
In 2025, we expect to execute approximately half of our ending 2024 backlog. (3) Includes backlog of $702 million and $1.3 billion for legacy projects in a loss position as of December 31, 2024 and 2023, respectively.
In 2026, we expect to execute approximately half of our ending 2025 backlog. (4) Includes backlog of $255 million and $702 million for legacy projects in a loss position as of December 31, 2025 and 2024, respectively.
We did not consider any cash to be permanently reinvested outside the U.S. as of December 31, 2024 and 2023, other than unremitted earnings required to meet our working capital and long-term investment needs in non-U.S. foreign jurisdictions where we operate.
We did not consider any cash to be permanently reinvested outside the U.S. as of December 31, 2025 and 2024, other than unremitted earnings required to meet our working capital and long-term investment needs in non-U.S. foreign jurisdictions where we operate. In 2025, we sold 15 million of our NuScale shares for net proceeds of $605 million.
Non-U.S. cash and cash equivalents amounted to $1.1 billion as of both December 31, 2024 and 2023. Non-U.S. cash and cash equivalents exclude deposits of U.S. legal entities that are invested in offshore, overnight accounts or short-term time deposits, to which there is unrestricted access.
Non-U.S. cash and cash equivalents exclude deposits of U.S. legal entities that are invested in offshore, overnight accounts or short-term time deposits, to which there is unrestricted access.
During 2024, we redeemed $57 million of aggregate outstanding 2028 Notes. During 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million and completed a tender offer in which we repurchased $115 million of outstanding 2024 Notes, excluding accrued interest, for consideration of $975.03 per $1,000 principal amount of the notes.
During 2023, we redeemed the remaining €129 million of outstanding 2023 Notes for $140 million and completed a tender offer in which we repurchased $115 million of outstanding 2024 Notes, excluding accrued interest, for consideration of $975.03 per $1,000 principal amount of the notes. In August 2023, we issued our 1.125% Convertible Senior Notes (the “2029 Notes”).
We generally use the cost-to-cost percentage-of-completion measure of progress as it best depicts how control transfers to our clients. The cost-to-cost approach measures progress towards completion based on the ratio of cost incurred to date compared to total estimated contract cost.
We recognize our engineering and construction contract revenue over time as we provide services to satisfy our performance obligations. We generally use the cost-to-cost percentage-of-completion measure of progress as it best depicts how control transfers to our clients. The cost-to-cost approach measures progress towards completion based on the ratio of cost incurred to date compared to total estimated contract cost.
Backlog is adjusted to reflect any known project cancellations, revisions to project scope and cost, foreign currency exchange fluctuations and project deferrals, as appropriate. Backlog differs from RUPO discussed elsewhere in this 10-K.
Although backlog reflects business that is considered to be firm, cancellations, deferrals or scope adjustments may occur. Backlog is adjusted to reflect any known project cancellations, revisions to project scope and cost, foreign currency exchange fluctuations and project deferrals, as appropriate. Backlog differs from RUPO discussed elsewhere in this 10-K.
In August 2023, we issued our 1.125% Convertible Senior Notes (the “2029 Notes”). The conversion rate for the 2029 Notes is 22.0420 shares of common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of $45.37 per share.
The conversion rate for the 2029 Notes is 22.0420 shares of common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of $45.37 per share.
These investments may include money market funds, bank deposits placed with highly-rated financial institutions, repurchase agreements that are fully collateralized by U.S. Government-related securities, high-grade commercial paper and high quality short-term and medium-term fixed income securities.
These investments may include money market funds, bank deposits placed with highly-rated financial institutions, repurchase agreements that are fully collateralized by U.S. Government-related securities, high-grade commercial paper and high quality short-term and medium-term fixed income securities. Capital expenditures in 2025 primarily related to investments in IT compared to expenditures for improvements to our new office lease in Houston in 2024.
In evaluating our liquidity needs, we consider cash and cash equivalents held by our consolidated variable interest entities (joint ventures and partnerships). These amounts (which totaled $333 million and $491 million as of December 31, 2024 and 2023, respectively) were not necessarily readily available for general purposes.
Cash and cash equivalents held by our consolidated variable interest entities (which totaled $328 million and $333 million as of December 31, 2025 and 2024, respectively) were not necessarily readily available for general purposes.
We have committed and uncommitted lines of credit available for revolving loans and letters of credit. We believe that for at least the next 12 months, anticipated cash generated from operations, along with our unused credit capacity and cash position, is sufficient to support operating requirements and debt maturities.
We believe that for at least the next 12 months, anticipated cash generated from operations, along with our unused credit capacity and cash position, is sufficient to support operating requirements and debt maturities. We regularly review our sources and uses of liquidity and may pursue opportunities to address our liquidity needs.
We regularly review our sources and uses of liquidity and may pursue opportunities to address our liquidity needs. Our credit facility contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, which is a one notch downgrade from both agencies' current ratings.
Our credit facility contains provisions that will require us to provide collateral to secure the facility should we be downgraded to BB by S&P and Ba2 by Moody's, which is a one notch downgrade from both agencies' current ratings. If we were required to provide collateral, it would consist broadly of liens on our U.S. assets.
We recognize the fair value of our investment in NuScale on a mark-to-market basis based upon the prevailing price of their stock on our balance sheet dates, which may subject our consolidated earnings to volatility. No estimates are used in the determination of the fair value of our investment in NuScale.
We elected the fair value option of accounting for our investment in NuScale that would have otherwise been recorded under the equity method of accounting. We recognize the fair value of our investment in NuScale on a mark-to-market basis based upon the prevailing price of their stock on our balance sheet dates, which may subject our consolidated earnings to volatility.
Distributions paid to holders of NCI represent cash outflows to partners of consolidated partnerships or joint ventures created primarily for the execution of single contracts or projects. Distributions in 2024 related to a Mission Solutions joint venture. During 2024, prior to deconsolidation, NuScale received $80 million in proceeds from the issuance of their common stock.
Distributions paid to holders of NCI represent cash outflows to partners of consolidated partnerships or joint ventures created primarily for the execution of single contracts or projects. Distributions in 2025 related to 2 consolidated infrastructure projects and a Mission Solutions joint venture. Distributions in 2024 related to the same Mission Solutions joint venture.
We record revenue on a gross basis, including CFM when we have concluded that we are a principal with respect to such materials and services, though the timing of CFM receipt can significantly impact completion percentage.
We record revenue on a gross basis, including CFM, when we have concluded that we are a principal with respect to such materials and services, though the timing of CFM receipt can significantly impact completion percentage. 35 Table of Contents Segment Operations Urban Solutions Revenue increased in 2025 due to the ramp up of execution activities on life sciences and mining and metal projects.
Certain events could cause the conversion rate to increase, including a make-whole fundamental change or redemption, but in no event will the conversion rate for a single note exceed 29.2056 shares of our common stock, other than for customary adjustments described in the applicable indenture.
Certain events could cause the conversion rate to increase, including a make-whole fundamental change or redemption, but in no event will the conversion rate for a single note exceed 29.2056 shares of our common stock, other than for customary adjustments described in the applicable indenture. 41 Table of Contents After August 2026, we may elect to redeem up to all of the outstanding 2029 Notes if our common stock has a prevailing per share closing price in excess of $58.98.
During 2024, the U.S. dollar appreciated against the Euro, British Pound, Canadian Dollar and Mexican Peso. Our profit margin percentages may be favorably or unfavorably impacted by a change in the amount of CFM recorded.
The OBBB Act did not have a material impact on our consolidated results. Our results were significantly impacted by evolving foreign currency rates in 2025. During 2025, the U.S. dollar depreciated against the Euro, British Pound, Canadian Dollar and Mexican Peso. Our profit margin percentages may be favorably or unfavorably impacted by a change in the amount of CFM recorded.
Financing Activities We have a stock repurchase program, authorized by our Board of Directors, to purchase shares in the open market or privately negotiated transactions at our discretion. In November 2024, the Board authorized an additional 20,000,000 shares to the repurchase program.
Financing Activities We have an ongoing stock repurchase program, authorized by our Board of Directors, to purchase shares in the open market or privately negotiated transactions at our discretion. During 2025, we repurchased 18 million shares of common stock under the repurchase program for total consideration of $754 million.
A typical trend for our lump-sum projects is to have higher cash balances during the initial phases of execution due to deposits paid to us which then diminish toward the end of the construction phase. As a result, our cash position is reduced as customer advances are utilized, unless they are replaced by advances on other projects.
Additionally, certain projects receive advance payments from clients. A typical trend for our lump-sum projects is to have higher cash balances during the initial phases of execution due to deposits paid to us which then diminish toward the end of the construction phase.
Unfunded backlog reflects our estimate of future revenue under awarded government contracts for which funding has not yet been appropriated. We do not report new awards or backlog for projects related to our equity method investments even though these awards may be significant contributors to earnings in future periods.
We do not report new awards or backlog for projects related to our equity method investments even though these awards may be significant contributors to earnings in future periods. Results for the fourth quarter of 2025.
Net earnings excluding amounts attributable to equity method earnings were as follows: YEAR ENDED DECEMBER 31, (in millions) 2024 Earnings before taxes $ 613 Income tax expense (634) Less: Income tax expense attributable to equity method earnings 376 Income tax expense and effective tax rate, excluding amount attributable to equity method earnings (258) 42 % Net earnings excluding amount attributable to equity method earnings $ 355 Equity method earnings $ 2,105 Income tax expense and effective tax rate attributable to equity method earnings (376) 18 % Equity method earnings, net of related income tax expense $ 1,729 Net earnings $ 2,084 34 Table of Contents The effective tax rate on earnings was 103%, 75% and 70% for 2024, 2023 and 2022, respectively.
Earnings before taxes decreased during 2025 due to the same factors that impacted revenue above as well as cost growth on 3 infrastructure projects for subcontracted design errors, price escalation and schedule impacts. 34 Table of Contents Net earnings (loss) excluding amounts attributable to equity method earnings were as follows: YEAR ENDED DECEMBER 31, (in millions) 2025 2024 Earnings (loss) before taxes $ (311) $ 613 Income tax benefit (expense ) 39 (634) Less: Income tax benefit (expense) attributable to equity method earnings 92 (376) Income tax expense and effective tax rate, excluding amount attributable to equity method earnings (53) (17) % (258) 42 % Net earnings (loss) excluding amount attributable to equity method earnings $ (364) $ 355 Equity method earnings $ 210 $ 2,105 Income tax benefit (expense) and effective tax rate attributable to equity method earnings 92 (44) % (376) 18 % Equity method earnings, net of related income tax expense $ 302 $ 1,729 Net earnings (loss) $ (62) $ 2,084 The effective tax rate on earnings, including equity method earnings, was 39%, 103% and 75% for 2025, 2024 and 2023, respectively.
Proceeds from sales of assets during 2024 included $67 million for the sale of our Stork's European business compared to $17 million for the sale of our AMECO South America business in 2023.
Net proceeds from sales of assets during 2025 included $61 million from the sale of Stork's U.K. operations compared to $67 million from the sale of Stork's European business in 2024.
We also funded an estimated $99 million on loss projects during 2024. Investing Activities We hold cash in bank deposits and marketable securities which are governed by our investment policy. This policy focuses on, in order of priority, the preservation of capital, maintenance of liquidity and maximization of yield.
In February 2026, we completed the sale of 71 million shares for proceeds of $1.35 billion. We hold cash in bank deposits and marketable securities which are governed by our investment policy. This policy focuses on, in order of priority, the preservation of capital, maintenance of liquidity and maximization of yield.
Working capital levels vary from period to period and are primarily affected by our volume of work and billing schedules on our projects. These levels are also impacted by the stage of completion and commercial terms of engineering and construction projects, as well as our execution of our projects compared to their budget.
These levels are also impacted by the stage of completion and commercial terms of engineering and construction projects, as well as our execution of our projects compared to their budget. Working capital requirements also vary by project as well as the payments terms agreed to with our clients, vendors and subcontractors. Most contracts require payments as the projects progress.
We will continue to repurchase shares of our stock throughout 2025 to return capital to our shareholders. 39 Table of Contents Year Ended December 31, (in millions) 2024 2023 2022 OPERATING CASH FLOW $ 828 $ 212 $ 31 INVESTING CASH FLOW Proceeds from sales and maturities (purchases) of marketable securities (60) (141) (64) Capital expenditures (164) (106) (75) NuScale cash deconsolidated (131) — — Proceeds from sales of assets (net of cash divested) 82 (5) 95 Investments in partnerships and joint ventures (93) (33) (53) Return of capital from partnerships and joint ventures 34 8 19 Other (1) — — Investing cash flow (333) (277) (78) FINANCING CASH FLOW Repurchase of common stock (125) — — Proceeds from issuance of 2029 Notes, net of issuance costs — 560 — Capped call transactions related to 2029 Notes — (73) — Purchases and retirement of debt (57) (249) (41) Proceeds from NuScale de-SPAC transaction — — 341 Proceeds from sale of NuScale interest 80 — 107 Dividends paid on CPS — (29) (39) Make-whole payment on conversion of CPS — (27) — Distributions paid to NCI (14) (53) (60) Capital contributions by NCI — 10 21 Other — (12) (14) Financing cash flow (116) 127 315 Effect of exchange rate changes on cash (69) 18 (38) Increase in cash and cash equivalents 310 80 230 Cash and cash equivalents at beginning of year 2,519 2,439 2,209 Cash and cash equivalents at end of year $ 2,829 $ 2,519 $ 2,439 Cash paid during the year for: Interest $ 42 $ 53 $ 54 Income taxes (net of refunds) 13 169 99 Noncash investing and financing activities: Marketable securities transferred to trustee to discharge the 2024 Notes $ — $ 262 $ — Debt assumed by buyer of Stork Latin America — 19 — Operating Activities Cash flows from operating activities result primarily from our core EPC activities and are affected by our earnings level and changes in working capital associated with such activities.
We are targeting approximately $1.4 billion in share repurchases in 2026, including $500 million in the first quarter. 39 Table of Contents Year Ended December 31, (in millions) 2025 2024 2023 OPERATING CASH FLOW (1) $ (387) $ 828 $ 212 INVESTING CASH FLOW Proceeds from the sale of NuScale shares 605 — — Proceeds from sales and maturities (purchases) of marketable securities 75 (60) (141) Capital expenditures (50) (164) (106) NuScale cash deconsolidated — (131) — Proceeds from sales of assets (net of cash divested) 63 82 (5) Investments in partnerships and joint ventures (278) (93) (33) Return of capital from partnerships and joint ventures 22 34 8 Other — (1) — Investing cash flow 437 (333) (277) FINANCING CASH FLOW Repurchase of common stock (754) (125) — Proceeds from issuance of 2029 Notes, net of issuance costs — — 560 Capped call transactions related to 2029 Notes — — (73) Purchases and retirement of debt (37) (57) (249) Proceeds from NuScale share issuance (net of issuance fees) — 80 — Dividends paid on CPS — — (29) Make-whole payment on conversion of CPS — — (27) Distributions paid to NCI (64) (14) (53) Capital contributions by NCI 65 — 10 Other (7) — (12) Financing cash flow (797) (116) 127 Effect of exchange rate changes on cash 53 (69) 18 Increase (decrease) in cash and cash equivalents (694) 310 80 Cash and cash equivalents at beginning of year 2,829 2,519 2,439 Cash and cash equivalents at end of year $ 2,135 $ 2,829 $ 2,519 (1) Operating cash flow in 2025 included a payment of $642 million to Santos, net of insurance recoveries, for a judgment related to a reimbursable project completed by us in 2015.
The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. Estimates are based on information available through the date of the issuance of the financial statements and, accordingly, actual results in future periods could differ from these estimates.
Our significant accounting policies are described in the notes to our financial statements. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities.
In December 2024, we repurchased 2,353,280 shares of common stock under the repurchase program for total consideration of $125 million. As of December 31, 2024, over 28,000,000 shares could still be purchased under the repurchase program. Key provisions of our debt and debt-related matters are described in the notes to the financial statements.
As of December 31, 2025, over 10 million shares could still be purchased under the repurchase program which was expanded by 30 million shares by our board in February 2026. Key provisions of our debt and debt-related matters are described in the notes to the financial statements.
G&A YEAR ENDED DECEMBER 31, (in millions) 2024 2023 2022 G&A Compensation $ 143 $ 165 $ 145 Facilities 15 14 16 Exit costs 13 6 7 SEC investigation — 1 38 Reserve for legacy legal claims — 3 5 Severance — 5 1 Gain on sale of land and buildings — — (11) All other 32 38 36 G&A $ 203 $ 232 $ 237 The decrease in compensation expense in 2024 was primarily driven by lower performance-based compensation.
G&A YEAR ENDED DECEMBER 31, (in millions) 2025 2024 2023 G&A Compensation $ 99 $ 143 $ 165 Severance and restructuring costs 43 13 11 Legal & professional fees 24 13 10 Facilities 7 15 14 Reserve for legacy legal claims 4 — 3 Other 19 19 29 G&A $ 196 $ 203 $ 232 The decrease in compensation expense in 2025 was primarily driven by lower stock price-driven compensation and performance-based compensation.
We may elect to pay any make-whole premium in any combination of cash and shares of our common stock. 41 Table of Contents In connection with the 2029 Notes offering, we entered into capped call transactions with certain banks. The strike price of the capped call options corresponds to the conversion price of the 2029 Notes of $45.37 per share.
In such election, all principal would be settled in cash and could result in a make-whole premium if the holders also elect to convert. We may elect to pay any make-whole premium in any combination of cash and shares of our common stock. In connection with the 2029 Notes offering, we entered into capped call transactions with certain banks.
New awards booked during 2024 included a full notice to proceed on a downstream project in Mexico. Backlog declined during 2024 due to the execution pace exceeding new award activity. Results for the fourth quarter of 2024.
Backlog declined during 2025 due to the execution pace exceeding new award activity. Results for the fourth quarter of 2025. Segment profit in the fourth quarter of 2025 was consistent with the fourth quarter of 2024.
Our cash balance as of December 31, 2023 includes cash held by NuScale of $118 million. With the deconsolidation of NuScale beginning in October 2024, cash balances held by NuScale are no longer included in our cash and cash equivalents. Cash and cash equivalents are held in numerous accounts throughout the world to fund our global project execution activities.
Cash and cash equivalents are held in numerous accounts throughout the world to fund our global project execution activities. Non-U.S. cash and cash equivalents amounted to $820 million and $1.1 billion as of December 31, 2025 and 2024.
Urban Solutions Revenue in 2024 significantly increased compared to 2023 primarily due to the ramp up of execution activities on several recently awarded projects including two life sciences projects, a large metals project, a green steel project and a large mining project.
However, revenue in both Urban Solutions and Mission Solutions increased in 2025 due to the ramp up of execution activities on life sciences and mining and metals projects and an increase in volume on a DOE project.
We maintain cash reserves and borrowing facilities to provide additional working capital in the event that a project’s net operating cash outflows exceed its available cash balances. As of December 31, 2024, our backlog included $702 million for ongoing legacy projects in a loss position, including approximately $237 million of estimated unfunded losses associated therewith.
As of December 31, 2025, our backlog included $255 million for ongoing legacy projects in a loss position, including approximately $212 million of estimated unfunded losses associated therewith. The comparable amounts in 2024 were $702 million of backlog and $237 million of unfunded losses.
Net Interest Income (Expense) The decrease in net interest income during 2024 was primarily due to a decrease in 2024 interest rates earned on cash deposits including at our joint ventures in Canada and Mexico as well as the interest savings following the extinguishment of our 2024 Notes at the end of 2023.
During 2025, we recognized severance and exit costs primarily related to certain international office closures. Net Interest Income (Expense) The decrease in net interest income during 2025 was primarily due to a decrease in interest rates as well as cash balances at certain of our larger joint ventures.
In December 2024, we used $125 million to repurchase and cancel 2,353,280 shares of common stock under our repurchase program. Over 28,000,000 shares could still be purchased under the repurchase program as of December 31, 2024. Between January 1, 2025 and February 14, 2025, we repurchased and canceled approximately 0.7 million shares of our common stock for $37 million.
During 2025, we used $754 million to repurchase and cancel 18 million shares of common stock under our repurchase program. Over 10 million shares could still be purchased under the repurchase program as of December 31, 2025, but in February 2026 our board authorized a 30 million share expansion to the repurchase program.
We recognize new awards into backlog when we and our client have approved the contract (written or verbal) and are committed to perform our respective obligations. Although backlog reflects business that is considered to be firm, cancellations, deferrals or scope adjustments may occur.
We do not report new awards or backlog for projects related to our equity method investments even though these awards may be significant contributors to earnings in future periods. We recognize new awards into backlog when we and our client have approved the contract (written or verbal) and are committed to perform our respective obligations.
Critical Accounting Policies and Estimates Our discussion and analysis of our financial condition and results of operations is based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. Our significant accounting policies are described in the notes to our financial statements.
Equity Method Earnings YEAR ENDED DECEMBER 31, (in millions) 2025 2024 Equity method earnings Gain (loss) on the fair value of our investment in NuScale $ (419) $ 2,221 Gain on the fair value of the forward sale contract of NuScale shares 208 — Gain on the sale of NuScale shares 336 — Other 85 (116) Equity method earnings $ 210 $ 2,105 Critical Accounting Policies and Estimates Our discussion and analysis of our financial condition and results of operations is based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.
We believe that total segment profit provides a meaningful perspective on our results as it is the aggregation of individual segment profit measures that we use to evaluate and manage our performance. (2) Backlog represents the total amount of revenue we expect to record in the future based upon contracts that have been awarded to us.
We believe that total segment profit provides a meaningful perspective on our results as it is the aggregation of individual segment profit measures that we use to evaluate and manage our performance. (3) During 2025, our backlog decreased due to the execution pace exceeding new award activity. We booked a multi-billion dollar award for a life sciences project during 2025.
Significant judgments and estimates used in the preparation of our financial statements apply to the following critical accounting policies: Revenue Recognition for Long-Term Contracts. We recognize our engineering and construction contract revenue over time as we provide services to satisfy our performance obligations.
Estimates are based on information available through the date of the issuance of the financial statements and, accordingly, actual results in future periods could differ from these estimates. Significant judgments and estimates used in the preparation of our financial statements apply to the following critical accounting policies: Revenue Recognition for Engineering & Construction Contracts.
Letters of Credit As of December 31, 2024, letters of credit totaling $483 million were outstanding under committed lines of credit.
During 2024, prior to its deconsolidation, NuScale received $80 million in proceeds from the issuance of their common stock. Letters of Credit As of December 31, 2025, letters of credit totaling $424 million were outstanding under committed lines of credit.
Recent Accounting Pronouncements Item is described more fully in the Notes to Financial Statements.
No estimates are used in the determination of the fair value of our investment in NuScale or the forward sale contract. Recent Accounting Pronouncements Item is described in the Notes to Financial Statements.
If we are required to provide collateral, it would consist broadly of liens on our U.S. assets. As of December 31, 2024, letters of credit totaling $483 million were outstanding under our $1.8 billion credit facility, which was amended in February 2025 to increase the facility to $2.2 billion and extend the maturity to February 2028.
As of December 31, 2025, letters of credit totaling $424 million were outstanding under our $2.2 billion credit facility, which matures in February 2028.
Developments in Our Business In the first quarter of 2024, we completed the sale of Stork's operations in continental Europe. During April 2024, we also entered into a definitive agreement to sell Stork's U.K. operations, which we completed in the first quarter of 2025.
Our divestiture of the Stork business was substantially completed following the sale of Stork's U.K. operations in 2025. Stork's operations in continental Europe were sold in 2024. In December 2025, we reached an agreement to sell our ownership in the fabrication yard in China for approximately $122 million.
Our staffing business does not report new awards or backlog. Results for the fourth quarter of 2024.
New awards in 2025 included a large multi-billion dollar pharmaceutical facility, two significant mining projects and construction contracts for 2 infrastructure projects. Backlog increased in 2025 due to the new award activity. Our staffing business does not report new awards or backlog. Results for the fourth quarter of 2025.
We completed the sale of Stork's U.K. operations in the first quarter of 2025. With the completion of the Stork U.K. divestiture, we expect the results of this segment to be immaterial in 2025.
In 2025, we completed the sale of Stork's operations in the U.K. and recognized a gain on sale of $7 million compared to an $11 million gain on the sale of Stork's operations in continental Europe in 2024. The results from our Other segment were immaterial for 2025.
Segment profit in the fourth quarter of 2024 significantly decreased due to the favorable settlement of a claim on an international bridge project during 2023. 35 Table of Contents Energy Solutions Revenue declined during 2024 primarily due to a decline in execution activity for several projects nearing completion, a deferral of revenue recognized on a large project due to reduced productivity and lower revenue on our refinery projects in Mexico as well as revenue on inflation-adjusted variable consideration recognized in 2023.
Revenue decreased in 2025 primarily due to the reversal of previously recognized revenue of $643 million for a judgment on the long-completed Santos project in Australia as well as a decline in execution activity for Energy Solutions projects nearing completion.